What Are the Closest Alternatives to SLU-PP-332?

At a Glance: Key SLU-PP-332 Research Alternatives

SLU-PP-332 is a synthetic estrogen-related receptor (ERR) agonist, specifically targeting ERRα, ERRβ, and ERRγ to promote oxidative skeletal muscle gene expression and mitochondrial biogenesis in preclinical models. When designing comparative in vitro or animal studies, researchers frequently examine alternative metabolic modulators and exercise mimetics to evaluate divergent molecular mechanisms.

Primary preclinical alternatives include mitochondrial-derived peptides like MOTS-c, direct AMPK activators such as AICAR, Rev-ErbA agonists like SR9009, and NNMT inhibitors like 5-Amino-1MQ. Each candidate influences cellular energy expenditure, fatty acid oxidation, or mitochondrial density through distinct signaling cascades.

Selecting the appropriate reference compound depends on your target receptor specificity, handling parameters, solubilization requirements, and baseline research goals. You can explore our full range of reference standards when you explore our full research catalog at PX1 Research.

What Is SLU-PP-332 and How Does It Function in Preclinical Research?

SLU-PP-332 was identified as a potent, small-molecule pan-agonist of the Estrogen-Related Receptor family (ERRα, ERRβ, and ERRγ), with highest operational affinity for ERRα. In preclinical mouse models and cultured myotubes, activation of ERRα by SLU-PP-332 upregulates an exercise-mimetic transcriptional program without requiring physical exertion.

Research indicates that SLU-PP-332 increases slow-twitch oxidative muscle fiber conversion, elevates basal oxygen consumption rate (OCR), enhances mitochondrial mass, and accelerates fatty acid oxidation in skeletal muscle tissue. Unlike traditional nuclear receptor ligands, ERRα agonists do not require direct estrogen binding; instead, they co-activate transcription factors such as PGC-1α.

To review structural specifications, analytical spectra, and assay protocols for this target, consult our comprehensive SLU-PP-332 research reference guide. For standardized dosing in solid-form assays, principal investigators frequently order SLU-PP-332 250 mcg capsules directly from our inventory.

Top SLU-PP-332 Alternatives for Laboratory Metabolic Investigations

1. **MOTS-c (Mitochondrial ORF from 12S rRNA Type-c)**: MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome. It translocates to the nucleus under metabolic stress to regulate nuclear gene expression, enhance insulin sensitivity, and promote fatty acid oxidation via the AMPK signaling pathway. Laboratories investigating mitochondrial-nuclear communication often compare MOTS-c directly against nuclear ERRα agonists. Investigators can examine MOTS-c 10 mg vials or review detailed bio-data on the MOTS-c mitochondrial peptide reference page.

2. **AICAR (Acadesine / 5-Aminoimidazole-4-carboxamide ribonucleoside)**: AICAR acts as an analog of adenosine monophosphate (AMP) that directly activates AMP-activated protein kinase (AMPK) without altering cellular ATP/ADP ratios. In preclinical models, AICAR administration stimulates glucose uptake, mitochondrial biogenesis, and fatty acid oxidation in skeletal muscle. It serves as a classic positive control for AMPK-mediated metabolic pathways alongside ERRα stimulation.

3. **SR9009 (Stenabolic)**: SR9009 is a synthetic Rev-ErbA receptor agonist that regulates circadian rhythms, lipid metabolism, and mitochondrial activity. In murine models, activation of Rev-Erbα by SR9009 increases mitochondrial content in skeletal muscle and suppresses lipogenic gene expression in liver tissue, making it a prominent small-molecule comparator to SLU-PP-332 in endurance and energy expenditure studies.

4. **5-Amino-1MQ**: A selective, membrane-permeable small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). By blocking NNMT activity in adipose tissue, 5-Amino-1MQ increases intracellular NAD+ and SAM levels, driving enhanced cellular metabolism and fat oxidation independent of direct nuclear receptor co-activation. Review technical data via our 5-Amino-1MQ NNMT inhibitor documentation.

5. **GW501516 (Cardarine)**: A selective peroxisome proliferator-activated receptor delta (PPARδ) agonist. Preclinical literature demonstrates that PPARδ activation shifts cellular energy utilization from glucose to fatty acids, upregulating genes associated with mitochondrial uncoupling and oxidative phosphorylation. PPARδ pathways frequently cross-talk with PGC-1α/ERRα networks in skeletal muscle assays.

Structured Comparison Breakdown: Target Receptors and Research Criteria

When designing comparative in vitro or preclinical experiments, selecting between SLU-PP-332 and alternative metabolic compounds requires analyzing key technical parameters. Below is a structured comparison based on published biochemical criteria:

**SLU-PP-332** - Primary Receptor Target: Pan-ERR agonist (ERRα, ERRβ, ERRγ; highest affinity for ERRα) - Compound Class: Synthetic small-molecule nuclear receptor ligand - Primary Evidence Base: In vitro myotube cultures, murine endurance models, metabolic disease models - Typical Supply Formats: Powder / oral solid capsule matrices - Handling Difficulty: Low to Moderate; solubilizes in DMSO, ethanol, or specialized oral carriers

**MOTS-c** - Primary Receptor Target: Nuclear transcriptomic targets via AMPK activation - Compound Class: Mitochondrial-derived peptide (16 amino acids) - Primary Evidence Base: Murine insulin-resistance models, cellular stress response assays - Typical Supply Formats: Lyophilized powder (10 mg vials) - Handling Difficulty: Moderate; requires sterile reconstitution in Bacteriostatic Water or PBS

**AICAR** - Primary Receptor Target: Direct enzymatic activation of AMPK - Compound Class: Nucleoside analog small molecule - Primary Evidence Base: Decades of preclinical skeletal muscle, glucose uptake, and exercise-mimetic literature - Typical Supply Formats: Lyophilized powder / pure crystalline solid - Handling Difficulty: Low; highly soluble in aqueous buffer systems

**SR9009** - Primary Receptor Target: Rev-Erbα and Rev-Erbβ nuclear receptors - Compound Class: Synthetic small molecule - Primary Evidence Base: Circadian gene regulation, lipid metabolism, oxidative muscle capacity in rodents - Typical Supply Formats: Crystalline powder / liquid solution matrices - Handling Difficulty: Moderate; hydrophobic, requires non-aqueous solvents (DMSO, PEG400)

Researchers seeking to benchmark ERRα specificity against broader mitochondrial pathways can buy SLU-PP-332 capsules for laboratory assays directly alongside peptide control standards from our catalog.

Comparing ERRα Agonism vs. AMPK Activation and Rev-ErbA Pathways

Understanding the mechanistic divergence between these research compounds is critical when establishing controls. SLU-PP-332 directly targets ERRα, which operates downstream of PGC-1α. This direct activation triggers the transcription of genes responsible for oxidative phosphorylation, mitochondrial electron transport chain complexes, and pyruvate dehydrogenase kinase 4 (PDK4) expression.

In contrast, compounds like AICAR and MOTS-c target the upstream metabolic sensor AMPK. AMPK senses cellular energy deficits (increased AMP/ATP ratio) and phosphorylates multiple downstream targets—including PGC-1α itself, ULK1 (autophagy), and ACC (acetyl-CoA carboxylase). While ERRα agonism specifically drives transcription of oxidative gene networks, AMPK activation initiates a broader cellular response including acute glucose transport via GLUT4 translocation.

Rev-ErbA agonists like SR9009 influence metabolism through the core circadian clock loop. Rev-ErbA represses BMAL1 transcription, suppressing lipogenesis in hepatic tissue while indirectly enhancing mitochondrial count in skeletal muscle. Researchers comparing these candidates often pair ERRα agonists with Rev-ErbA or AMPK reagents to map overlapping regulatory circuits in metabolic research. Detailed study protocols can be explored in our preclinical research library.

Vendor Evaluation Matrix: How to Vet a Research Compound Supplier

Reliable experimental data requires absolute compound purity, accurate concentration, and freedom from toxic contaminants. Whether acquiring small molecules like SLU-PP-332 or complex peptides, evaluate suppliers against these mandatory operational standards:

- **Purity Verification**: High-Performance Liquid Chromatography (HPLC) showing single-peak identity and purity consistently exceeding 98.0%.

- **Structural Identity**: Mass Spectrometry (ESI-MS or MALDI-TOF) verifying exact molecular weight and chemical structure matching published standards.

- **Lot Traceability**: Every vial or bottle must bear a distinct lot number linked to an independently generated Certificate of Analysis (COA) accessible to researchers.

- **Endotoxin & Bioburden Data**: Limulus Amebocyte Lysate (LAL) testing guaranteeing bacterial endotoxin levels remain below strictly defined thresholds (<0.05 EU/mg) for cellular safety.

- **Sourcing & Synthesis**: Domestically synthesized and processed reagents managed under rigid quality control standards rather than unverified overseas drop-shipping.

- **Shipping Speed & Storage Control**: Cold-chain preservation or humidity-controlled storage prior to same-day dispatch from domestic distribution centers.

- **Technical Support**: Direct access to scientific support teams qualified to provide analytical data sheets, solubility guidelines, and reconstitution parameters.

Red Flags When Sourcing Exercise Mimetics and ERRα Agonists Online

The growing scientific interest in metabolic research compounds has led to an influx of unverified suppliers online. Principal investigators and laboratory buyers must maintain rigorous standards when sourcing reagents. Be vigilant for the following red flags:

1. **Generic or Reused COAs**: Suppliers displaying a single, static COA on their website without matching lot numbers on shipped physical containers. Real quality control requires batch-specific testing for every single production run.

2. **Human Administration or Medical Claims**: Vendors marketing compounds with human dosing charts, sublingual protocol recommendations, or health claim terminology. True scientific supply vendors restrict all catalog items exclusively to in vitro and preclinical research applications.

3. **Lack of Mass Spectrometry Data**: Offering HPLC purity reports without MS structural confirmation leaves open the risk of misidentified synthetic isomers or related structural impurities.

4. **Opaque Business Logistics**: Companies operating through anonymous foreign addresses without verified USA distribution points, leading to extended transit times and uncontrolled thermal degradation.

PX1 Research eliminates these risks by publishing verified HPLC, MS, and endotoxin data for every single lot, ensuring uncompromised experimental validity for your research facility. Institutional accounts can submit bulk research compound inquiries for specialized quote processing.

Laboratory Handling, Solvability, and Storage Standards

Proper handling and stock solution preparation are critical when working with SLU-PP-332 and alternative metabolic compounds to prevent precipitation, degradation, or loss of potency during long-term assays.

For small molecules like SLU-PP-332 and SR9009, stock solutions are generally prepared using dimethyl sulfoxide (DMSO) or ethanol. SLU-PP-332 exhibits limited solubility in pure aqueous buffers, making organic solvent pre-dissolution mandatory prior to dilution in cell culture media (maintaining final DMSO concentrations below 0.1% v/v for cell viability). Solid oral capsule matrices should be extracted or solubilized according to standardized analytical protocols.

For peptide alternatives like MOTS-c, reconstitution requires sterile Bacteriostatic Water or phosphate-buffered saline (PBS). Lyophilized powders should be stored at -20°C or -80°C upon receipt. Avoid repeated freeze-thaw cycles of reconstituted peptide stocks by preparing single-use aliquots. All compounds from PX1 Research arrive sealed in climate-stabilized packaging with complete handling notes.

Ordering SLU-PP-332 and Related Compounds from PX1 Research

When purchasing metabolic research compounds for your laboratory, speed, consistency, and compliance are paramount. PX1 Research simplifies procurement by maintaining fully stock-managed domestic inventory across dual fulfillment hubs in California and Arizona.

Orders placed before our daily cutoff (4:00 PM EST, Monday through Friday) ship same-day via tracked domestic carrier services. Every package contains sealed, lot-coded vials or capsule matrices matching the exact analytical Certificate of Analysis published in our database. Every batch undergoes rigorous 3rd-party verification using HPLC, Mass Spectrometry, and LAL endotoxin testing.

Whether your protocol calls for ERRα agonists, mitochondrial peptides, or AMPK pathways, PX1 Research provides the analytical integrity your publication requires. Review complete technical specifications and order SLU-PP-332 250 mcg capsules to ensure reliable experimental outcomes today.